Suppr超能文献

COVID-19 感染导致急性脓疱性皮肤病。

COVID-19 infection leading to acute pustular dermatoses.

机构信息

Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N St. Clair St, Suite 1600, Chicago, IL, 60607, USA.

Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Arch Dermatol Res. 2023 May;315(4):685-697. doi: 10.1007/s00403-022-02450-z. Epub 2022 Nov 1.

Abstract

Viral infections, including SARS-CoV-2, the virus that causes COVID-19 infection, have been implicated in the development of pustular dermatoses, including generalized pustular psoriasis (GPP) and acute generalized exanthematous pustulosis (AGEP). We performed a literature review of existing cases of GPP and AGEP associated with COVID-19 infection and/or treatment reported over a period of 12 months. We summarize the clinical characteristics of these cases and report an additional six new cases of GPP and AGEP. Seven patients with COVID-19 infection were diagnosed with new-onset or exacerbated GPP, and 33 patients were diagnosed with AGEP. In 55% of the cases, no concomitant potential culprit drug trigger was identified. We present this review of cases of COVID-associated acute pustular dermatoses to further contribute to the spectrum of cutaneous eruption associated with SARS-CoV-2 infection.

摘要

病毒感染,包括导致 COVID-19 感染的 SARS-CoV-2 病毒,已被牵连到脓疱性皮肤病的发展中,包括泛发性脓疱性银屑病(GPP)和急性泛发性发疹性脓疱病(AGEP)。我们对过去 12 个月内报告的与 COVID-19 感染和/或治疗相关的 GPP 和 AGEP 现有病例进行了文献复习。我们总结了这些病例的临床特征,并报告了另外六例新的 GPP 和 AGEP 病例。7 例 COVID-19 感染患者被诊断为新发或加重的 GPP,33 例患者被诊断为 AGEP。在 55%的病例中,未发现同时存在潜在的致病药物触发因素。我们对这些与 COVID 相关的急性脓疱性皮肤病的病例进行回顾,以进一步补充与 SARS-CoV-2 感染相关的皮肤疹谱。

相似文献

1
COVID-19 infection leading to acute pustular dermatoses.
Arch Dermatol Res. 2023 May;315(4):685-697. doi: 10.1007/s00403-022-02450-z. Epub 2022 Nov 1.
2
Antibody tests for identification of current and past infection with SARS-CoV-2.
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
6
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
8
Epidemiology and Health Care of Generalized Pustular Psoriasis in Germany - Methodology and Outcomes of Claims Data Analysis.
Psoriasis (Auckl). 2025 Jul 15;15:273-283. doi: 10.2147/PTT.S529515. eCollection 2025.
9
Global Delphi consensus on treatment goals for generalized pustular psoriasis.
Br J Dermatol. 2025 Mar 18;192(4):706-716. doi: 10.1093/bjd/ljae491.
10
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.

引用本文的文献

1
Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China.
Am J Clin Exp Immunol. 2024 Jun 25;13(3):117-132. doi: 10.62347/BDUC7952. eCollection 2024.
2
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries.
Psoriasis (Auckl). 2024 May 14;14:29-38. doi: 10.2147/PTT.S451666. eCollection 2024.
3
SARS-CoV-19 and Generalised Pustular Psoriasis: A Lethal Combination.
Indian J Dermatol. 2023 Nov-Dec;68(6):726. doi: 10.4103/ijd.ijd_914_22. Epub 2024 Jan 9.
4
A case of acute generalized exanthematous pustulosis following COVID-19 infection and remdesivir.
Clin Case Rep. 2023 May 29;11(6):e7423. doi: 10.1002/ccr3.7423. eCollection 2023 Jun.
5
Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets.
Front Mol Biosci. 2023 Apr 26;10:1157651. doi: 10.3389/fmolb.2023.1157651. eCollection 2023.

本文引用的文献

1
Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
Am J Dermatopathol. 2021 May 1;43(5):342-348. doi: 10.1097/DAD.0000000000001819.
2
Presentation and Management of Cutaneous Manifestations of COVID-19.
J Drugs Dermatol. 2021 Jan 1;20(1):76-83. doi: 10.36849/JDD.5676.
4
Pustular psoriasis exacerbated by COVID-19 in a patient with the history of psoriasis.
Dermatol Ther. 2020 Nov;33(6):e14462. doi: 10.1111/dth.14462. Epub 2020 Nov 5.
5
New-onset pustular psoriasis in the setting of infection causing coronavirus disease 2019.
JAAD Case Rep. 2020 Dec;6(12):1360-1362. doi: 10.1016/j.jdcr.2020.10.013. Epub 2020 Oct 16.
7
Late-onset AGEP-like skin pustular eruption following COVID-19: A possible association.
Dermatol Ther. 2020 Nov;33(6):e14275. doi: 10.1111/dth.14275. Epub 2020 Sep 14.
8
Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine.
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e5-e7. doi: 10.1111/jdv.16903. Epub 2020 Sep 17.
9
Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression.
Physiology (Bethesda). 2020 Sep 1;35(5):288-301. doi: 10.1152/physiol.00019.2020.
10
Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
Dermatol Ther. 2020 Nov;33(6):e13834. doi: 10.1111/dth.13834. Epub 2020 Jul 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验